Preventive Analgesic Efficacy of Nefopam in Acute and Chronic Pain after Breast Cancer Surgery

Medicine (United States)

Volumn 95, Issue 20, 2016, Pages

  Na, Hyo Seok ^a   Oh, Ah Young ^a,c   Koo, Bon Wook ^a   Lim, Dae Jin ^b   Ryu, Jung Hee ^a,c   Han, Ji Won ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Department of Anesthesiology and Pain Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; KETOROLAC; MELOXICAM; NEFOPAM; ANALGESIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; NEURALGIA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN INTENSITY; PARTIAL MASTECTOMY; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SENTINEL LYMPH NODE BIOPSY; SEROMA; SURGICAL INFECTION; ACUTE PAIN; ADJUVANT CHEMORADIOTHERAPY; ADVERSE EFFECTS; AGED; AXILLA; BREAST NEOPLASMS; COMBINATION DRUG THERAPY; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PREOPERATIVE CARE; PROSPECTIVE STUDY;

ACUTE PAIN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; AXILLA; BREAST NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; CHRONIC PAIN; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KETOROLAC; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEFOPAM; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; THIAZINES; THIAZOLES;

EID: 85013764390     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003705     Document Type: Article

References (34)

1. Fecho K, Miller NR, Merritt SA, et al. Acute and persistent postoperative pain after breast surgery. Pain Med. 2009;10:708-715.
2. Andersen KG, Duriaud HM, Jensen HE, et al. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015;156:2413-2422.
3. Katz J, Jackson M, Kavanagh BP, et al. Acute pain after thoracic surgery predicts long-Term post-Thoracotomy pain. Clin J Pain. 1996;12:50-55.
4. Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth. 2001;48:1000-1010.
5. Girard P, Chauvin M, Verleye M. Nefopam analgesia and its role in multimodal analgesia: A review of preclinical and clinical studies. Clin Exp Pharmacol Physiol. 2016;43:3-12.
6. McLintock TT, Kenny GN, Howie JC, et al. Assessment of the analgesic efficacy of nefopam hydrochloride after upper abdominal surgery: A study using patient controlled analgesia. Br J Surg. 1988;75:779-781.
7. Du Manoir B, Aubrun F, Langlois M, et al. Randomized prospective study of the analgesic effect of nefopam after orthopaedic surgery. Br J Anaesth. 2003;91:836-841.
8. Delage N, Maaliki H, Beloeil H, et al. Median effective dose (ED50) of nefopam and ketoprofen in postoperative patients: A study of interaction using sequential analysis and isobolographic analysis. Anesthesiology. 2005;102:1211-1216.
9. Laboureyras E, Chateauraynaud J, Richebe P, et al. Long-Term pain vulnerability after surgery in rats: prevention by nefopam, an analgesic with antihyperalgesic properties. Anesth Analg. 2009;109:623-631.
10. Nam JS, Cheong YS, Karm MH, et al. Effects of nefopam on streptozotocin-induced diabetic neuropathic pain in rats. Korean J Pain. 2014;27:326-333.
11. Aveline C, Roux AL, Hetet HL, et al. Pain and recovery after total knee arthroplasty: A 12-month follow-up after a prospective randomized study evaluating nefopam and ketamine for early rehabilitation. Clin J Pain. 2014;30:749-754.
12. Fuller RW, Snoddy HD. Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice. Neuropharmacology. 1993;32:995-999.
13. Verleye M, Andre N, Heulard I, et al. Nefopam blocks voltagesensitive sodium channels and modulates glutamatergic transmission in rodents. Brain Res. 2004;1013:249-255.
14. Marks DM, Shah MJ, Patkar AA, et al. Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise. Curr Neuropharmacol. 2009;7:331-336.
15. Petrenko AB, Yamakura T, Baba H, et al. The role of N-methyl-Daspartate (NMDA) receptors in pain: A review. Anesth Analg. 2003;97:1108-1116.
16. Hopwood P, Haviland JS, Sumo G, et al. Comparison of patientreported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11:231-240.
17. Whelan TJ, Levine M, Julian J, et al. The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer. 2000;88:2260-2266.
18. Rosero EB, Joshi GP. Preemptive, preventive, multimodal analgesia: what do they really mean? Plast Reconstr Surg. 2014;134(Suppl 2):85S-93S.
19. Karmakar MK, Samy W, Li JW, et al. Thoracic paravertebral block and its effects on chronic pain and health-related quality of life after modified radical mastectomy. Reg Anesth Pain Med. 2014;39:289-298.
20. Chiu M, Bryson GL, Lui A, et al. Reducing persistent postoperative pain and disability 1 year after breast cancer surgery: A randomized, controlled trial comparing thoracic paravertebral block to local anesthetic infiltration. Ann Surg Oncol. 2014;21:795-801.
21. Blumenthal S, Dullenkopf A, Rentsch K, et al. Continuous infusion of ropivacaine for pain relief after iliac crest bone grafting for shoulder surgery. Anesthesiology. 2005;102:392-397.
22. McCartney CJ, Sinha A, Katz J. A qualitative systematic review of the role of N-methyl-D-Aspartate receptor antagonists in preventive analgesia. Anesth Analg. 2004;98:1385-1400.
23. Biella GE, Groppetti A, Novelli A, et al. Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine. J Neurotrauma. 2003;20:593-601.
24. Gregori-Puigjane E, Setola V, Hert J, et al. Identifying mechanismof-Action targets for drugs and probes. Proc Natl Acad Sci USA. 2012;109:11178-11183.
25. Kim KH, Abdi S. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain. 2014;27:103-111.
26. Jung BF, Ahrendt GM, Oaklander AL, et al. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104:1-13.
27. Langford DJ, Paul SM, West C, et al. Persistent arm pain is distinct from persistent breast pain following breast cancer surgery. J Pain. 2014;15:1238-1247.
28. Cho Y, Do J, Jung S, et al. Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection. Support Care Cancer. 2016;24:2047-2057.
29. Armer J, Fu MR, Wainstock JM, et al. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37:73-91.
30. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998;83(Suppl American):2776-2781.
31. Langer I, Guller U, Berclaz G, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245: 452-461.
32. Gergich NLS, Pfalzer LA, McGarvey C, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809-2819.
33. Lacomba MT, Del Moral OM, Zazo JLC, et al. Axillary web syndrome after axillary dissection in breast cancer: A prospective study. Breast Cancer Res Treat. 2009;117:625-630.
34. Koehler LA, Blaes AH, Haddad TC, et al. Movement, function, pain, and postoperative edema in axillary web syndrome. Phys Ther. 2015;95:1345-1353.